Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples